Beta Drugs Limited (BETA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE351Y01019
₹2,194.20+0.00 (+0.00%)
Key metrics
- Market Cap
- ₹2,222 Cr
- P/E Ratio
- 49.91
- EPS
- 44.1
- Book Value
- —
- P/B Ratio
- —
- ROE
- 16.95%
- ROCE
- 14.91%
- Debt / Equity
- 0.6
- Net Margin
- 10.78%
- Revenue Growth
- 6.2%
- Profit Growth
- -2.21%
- Dividend Yield
- —
- 52W High
- ₹2,807.90
- 52W Low
- ₹990.10
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Beta Drugs Limited
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
- Headquarters
- Panchkula, India
The full Beta Drugs Limited analysis
Create a free account to open the complete BETA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.